Overview

Persica 002 Phase 1b PP353 vs Placebo in the Treatment of Low Back Pain

Status:
Recruiting
Trial end date:
2023-02-01
Target enrollment:
Participant gender:
Summary
A Phase 1b study to investigate the efficacy of PP353 compared to placebo in the treatment of chronic low back pain associated with bone oedema.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Persica Pharmaceuticals Ltd
Collaborator:
Micron Research Ltd